Measuring mutation levels in siblings with BRCA risk
Part of Cancer, Skin clinical trials.
This study looks at how genetic mutations (changes in DNA) are measured in the blood of sisters. One sister has a BRCA1 or BRCA2 gene mutation that raises cancer risk, and the other does not. The goal is to understand mutation differences between them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman between 30 and 50 years old.
- You and your biological sister must both agree to take part.
- One sister has a BRCA1 or BRCA2 gene mutation (known hereditary risk), and the other does not.
- You must be getting regular cancer genetics follow-up at the Centre François Baclesse.
- You must be enrolled in French social security health insurance.
- You must sign a consent form before any study procedures begin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at women with a strong family history of breast cancer or with gene changes that increase risk. It aims to learn more about inherited breast cancer in China and may help doctors offer better care.
This study tests if a simple blood or fluid test can find cancer early in people with a higher-than-average risk. If you have certain genetic mutations, a strong family history of cancer, or other high-risk conditions, you may be able to join.
This is an observational study that looks at how different cancer prevention approaches affect women with harmful (deleterious) BRCA1 or BRCA2 mutations. It may help improve future prevention and follow-up plans for women at higher inherited risk.
This study creates a platform for women who carry a BRCA1 or BRCA2 gene mutation to be followed over time. It aims to better understand and manage cancer risks associated with these mutations.
This study follows people who carry a harmful BRCA1 or BRCA2 gene mutation, whether or not they currently have breast or ovarian cancer. The goal is to better understand cancer risk over time and how being a carrier may affect screening and care.
This study looks at fertility in women who carry a BRCA1 or BRCA2 gene mutation. It aims to understand how these mutations might affect a woman's ability to have children by comparing them to family members without the mutation.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.